FDA proposes new policy for some devices

The U.S. Food and Drug Administration (FDA) has proposed a new policy that reduces  premarket notification requirements related to devices that have had their safety and efficacy well proven, for example, blood clotting tests and common urine and blood tests. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here